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This section looks back to some ground-breaking contributions to public health, reproducing them in their original
form and adding a commentary on their significance from a modern-day perspective. To complement the theme of
this month’s Bulletin, Thomas C. Quinn reviews the paper he co-authored in 1986 on AIDS in Africa. The original
paper is reproduced by permission of the American Association for the Advancement of Science.
AIDS in Africa: a retrospective
Thomas C. Quinn1
In 1983, two years after the initial recognition of
AIDS in the USA (1, 2), a series of investigations was
initiated in central Africa to determine the extent of
the clinical problem of AIDS and to examine its
transmission patterns within the African region.
These first investigations of AIDS in Africa were
prompted by the finding of clinical AIDS cases
among Africans residing in Europe, which differed
from cases among Europeans by having a nearly
equal male-to-female ratio and 90% had no identifi-
able risk factors (3–6). Two sentinel reports
published one year later documented the presence
ofAIDS in selected urban centres of equatorial Africa
(7, 8). Clinically, these cases were recognized by life-
threatening enteropathic illnesses referred to as ‘‘slim
disease,’’ oesophageal candidiasis, Kaposi’s sarcoma,
and cryptococcal meningitis (9–11). Most of these
studies on clinical cases suggested that while the
disease may have been endemic in Africa, it did not
become truly epidemic until the late 1970s and early
1980s, a pattern similar to that in the United States
and Haiti.
The most unusual characteristics of AIDS
among Africans were the equal distribution of cases
between men and women and the high frequency of
cases among commercial sex workers and their
clients. In contrast to the industrialized world where
the epidemic was entrenched among homosexual
men and injecting drug users, there was little or no
evidence for this pattern in Africa. This raised a series
of debates regarding the modes of transmission in
Africa, which ultimately was resolved following the
introduction of serological tests for HIV-1, allowing
for more detailed epidemiological studies on trans-
mission, and investigations into the natural history
and clinical presentation of HIV infections (12–16).
Two years of detailed studies in Kinshasa, Zaire (now
the Democratic Republic of the Congo) were
presented in our paper entitled ‘‘AIDS in Africa: an
epidemiologic paradigm’’ (17), which is reproduced
in the following pages. From these early investiga-
tions in Kinshasa, it was evident by 1986 that HIV/
AIDS was an escalating epidemic in central Africa
with an estimated annual incidence of AIDS of 550–
1000 cases per million adults, with 1–18% of healthy
blood donors and pregnant women infected with
HIV, and 27–88% of female commercial sex workers
serologically positive for HIV. Our early estimate of
HIV incidence in central and east Africa was 0.75%
among the general population. In addition, we found
that themale-to-female ratio of cases was 1:1with age
and sex-specific rates slightly greater in females
<30 years of age and greater in males over age 40. It
was evident that the epidemic was moving rapidly,
being spread predominantly by heterosexual trans-
mission, parenteral exposure to unscreened blood
transfusions and unsterilized needles, and perinatally
from infected mothers to newborns. The seeds for a
massive epidemic had been sown and it was
increasingly evident to clinicians and epidemiologists
working in Africa that, unless a vigorous control
programme was initiated in the region, the prevailing
economic and cultural factors would favour these
modes of transmission and the epidemic would
extend to the entire continent.
Although we knew the problem was severe in
1986, none of uswould have predicted themagnitude
the epidemic would reach today. In 1986 we
projected that the annual number of AIDS cases
would be 400 000, whereas in 2000 there were three
million (18). We estimated that 1–2 million Africans
were HIV-infected in 1986, whereas today 25.3 mil-
lion Africans are infected and the adult prevalence for
the continent is now 8.8% (18).We estimated in 1986
that the annual incidence of infection was 0.75%
among the general population, and today incidence
rates range from 1.5% to 3% in rural populations, and
from 5% to 15% among higher risk populations (19).
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Overall, 3.8 million Africans became newly infected
last year alone. Since the beginning of the epidemic,
5.7 million children have been infected with HIV, of
whom 4.3 million have already died. In 2000,
UNAIDS estimated that over 13 million children in
Africa had been orphaned by the premature death of
both parents due to AIDS (18).
Most of the epidemiological trends described
in the original report continue today, with few
exceptions. Throughout the region, men and women
between the ages of 20 and 40 years, people with
sexually transmitted diseases, and occupational
groups such as long-distance truck drivers, military
personnel, and female commercial sex workers have
the highest infection rates (20). HIV prevalence of
more than 80% has been reported for female sex
workers in eastern, central, and southern Africa (21).
Seroprevalence of HIV among pregnant women now
ranges from 5% to 35%, with the highest rates among
those in urban centres such as Abidjan, Blantyre,
Kampala, and Lusaka. There are now 16 countries in
which more than 10% of the adult population aged
15–49 years is infected with HIV (21). In seven
countries in the southern cone of the continent, at
least one in five adults is living with HIV. In
Botswana a disturbing 36% of pregnant women are
now infected with HIV, while in South Africa 22%
are infected.
The initial clinical descriptions of immunosup-
pression with a selection of opportunistic infections
and endemic diseases, including tuberculosis, and the
modes of transmission have essentially remained
unchanged since our original report. What has
changed has been the overall magnitude and impact
of the epidemic in sub-Saharan Africa. The human
toll of this epidemic is becoming increasingly difficult
to describe. Last year over 2.4 million people died
from AIDS in Africa, resulting in a cumulative total
of 17.2 million deaths from AIDS in the region (18).
AIDS is now the leading cause of death, being
responsible for 20% of all fatalities in the region. In
addition to the personal suffering that accompanies
HIV infection, the virus in sub-Saharan Africa
threatens to devastate whole communities, reversing
many decades of progress toward a healthy and more
prosperous future. Because AIDS deaths are con-
centrated in childhood and young adulthood, their
effects are substantial. Within the next ten years, 8–
31 years of average life expectancy will have been lost
in those countries most affected by HIV/AIDS in
sub-Saharan Africa (21). These additional HIV/
AIDS cases place increasing strain on the health care
systems that are already overburdened, and on
individual households that are trying to manage with
limited economic resources (22). Care and support
for AIDS orphans is a growing concern throughout
the region. Thus, it was an understatement to say in
1986 that the impact of AIDS socially, economically,
and demographically would be enormous: because of
its widely destabilizing effects superimposed on an
already fragile and complex geopolitical system,
AIDS has become a key issue for human security in
sub-Saharan Africa. Within the last two years the
world’s attention has been directed to this growing
problem of AIDS in Africa, ushering in increasing
resources for improved prevention programmes and,
hopefully, for antiretroviral care for people already
infected.
It was evident in 1986, as it is now, that to
respond to the AIDS epidemic an effective plan of
action had to be developed, whichwas initiated under
the auspices of the World Health Organization
Regional Office for Africa (17). The ultimate goal
of these strategies was to lead rapidly to the
development of programmes to halt the spread of
the AIDS virus. Creative educational approaches,
changes in medical practice, the screening of women
of childbearing age, and counselling regarding
contraception were hoped to be effective in stem-
ming the tide of the epidemic. It was felt that these
activities had to be integrated into existing health and
educational programmes in order to be successful
and that they would require full support by
appropriate government agencies. However, to
support really effective intervention and control,
international commitment would be required in the
form of financial aid and scientific, educational, and
technical assistance. Only history will judge whether
the international commitment was strong enough to
slow the epidemic, and I leave readers to make their
own assessment of the response to the problem
between 1986 and 2001.
It is of interest that two of the co-authors of
this paper, the late Jonathan Mann and Peter Piot,
rose to the challenge of trying to spearhead world-
wide control of the AIDS epidemic. Jonathan Mann
became the first Director of the WHO Global
Programme on AIDS and, later, Peter Piot became
theExecutiveDirector ofUNAIDS. Their tasks have
been formidable, as the HIV/AIDS epidemic has
marched relentlessly throughout the sub-Saharan
African region and many other areas of the world.
However, there are some glimmers of hope on the
horizon which might stem the tide of the epidemic.
Uganda was one of the first countries in Africa to
recognize the danger of HIV to national develop-
ment, and the government took steps to fight its
spread through action by political and religious
leaders and community development organizations.
This broad-based approach to the epidemic con-
tributed to a reduction in HIV infection among
young, pregnant women living in towns and cities
(18, 21). Condom use is increasing among young
people, but unfortunately these changes are limited
and are taking place against a backdrop of very high
prevalence that limits their overall effectiveness.
The introduction of nevirapine in Uganda and
other African countries to prevent mother-to-infant
transmission has the potential to slow dramatically
the spread of HIV among newborn infants (23).
Unfortunately, enormous obstacles still exist in terms
of an inadequate clinical infrastructure, limited
counselling and testing of all pregnant women, and
few or no drug delivery programmes, though changes
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are occurring. With recent reductions in the price of
antiretroviral drugs for Africa — and with the
development of the Global Fund for AIDS,
Tuberculosis, and Malaria — there is renewed
optimism that antiretroviral drugs may soon be made
available to those afflicted with AIDS.Unfortunately,
while the developed world shares in the benefits of
these drugs in terms of increased survival, decreased
mortality, and decreased hospitalizations, fewer than
1% of AIDS patients in Africa have access to
antiretroviral therapy.
In a sense, it is a sad commentary that the
conclusions and recommendations that can be
made today are in fact similar to those we made
in 1986. What has changed is that the epidemic is
now much worse, millions more have died or have
been orphaned, and the effects of the epidemic are
even more profound in African communities. In
retrospect, if we thought the AIDS epidemic had
reached a crisis in 1986, then it is now a medical
emergency of unprecedented proportions that
threatens the social, economic, and cultural frame-
work of Africa. Such an epidemic requires im-
mediate and unprecedented international assistance
to support effective interventions to prevent
transmission and to provide financial resources
for care of those already infected and suffering from
AIDS. n
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